Post on 16-Jul-2015
Diabetic Retinopathy Diabetic Retinopathy Presentation and Presentation and
ClassificationClassificationDr Anand SudhalkarDr Anand Sudhalkar
05/13/10 2Eye Hospital & Retinal Laser Centre, Baroda
PROLONGED Hyperglycemia PROLONGED Hyperglycemia complications :complications :
END STAGE RENAL DISEASEEND STAGE RENAL DISEASE RETINOPATHYRETINOPATHY NON-TRAUMATIC LOWER LIMB NON-TRAUMATIC LOWER LIMB
AMPUTATIONSAMPUTATIONS
05/13/10 3Eye Hospital & Retinal Laser Centre, Baroda
END STAGE RENAL DISEASE END STAGE RENAL DISEASE AND RETINOPATHY: AND RETINOPATHY:
DENMARK STUDY DENMARK STUDY TI: Incidence of retinopathy in type I (insulin-TI: Incidence of retinopathy in type I (insulin-
dependent) diabetes: association with clinical dependent) diabetes: association with clinical nephropathy.nephropathy.
AU: Kofoed-Enevoldsen-A; Jensen-T; Borch-Johnsen-AU: Kofoed-Enevoldsen-A; Jensen-T; Borch-Johnsen-K; Deckert-TK; Deckert-T
SO: J-Diabet-Complications. 1987 Jul-Sep; 1(3): 96-9SO: J-Diabet-Complications. 1987 Jul-Sep; 1(3): 96-9 110 IDDM 5 YEARS FOLLOWUP110 IDDM 5 YEARS FOLLOWUP PDR IN 74% WITH PROTEINUREA, AGAINST PDR IN 74% WITH PROTEINUREA, AGAINST
14% IN WITHOUT.14% IN WITHOUT. BDR IN 93% WITH AND 37% WITHOUT BDR IN 93% WITH AND 37% WITHOUT
PROTEINUREA.PROTEINUREA.
05/13/10 4Eye Hospital & Retinal Laser Centre, Baroda
PREVALENCE OF PREVALENCE OF RETINOPATHYRETINOPATHY
10% AMONGST ALL DM10% AMONGST ALL DM 40% Of these have CSME40% Of these have CSME Out of all BDR 3% have CSMEOut of all BDR 3% have CSME Out of all PPDR 38% have CSMEOut of all PPDR 38% have CSME out of all PDR 71% have CSMEout of all PDR 71% have CSME 5% of maturity-onset, IDDM at diag.5% of maturity-onset, IDDM at diag. Prevalence Prevalence ↑↑ Duration of Hyperglycemia Duration of Hyperglycemia After 20 yr. 99% of IDDM and 60% of NIDDM After 20 yr. 99% of IDDM and 60% of NIDDM
have retinopathyhave retinopathy
05/13/10 5Eye Hospital & Retinal Laser Centre, Baroda
83.0
2.0
15.0
51.7
10.3
37.931.5
25.0
43.5
0.00
10.00
20.0030.00
40.00
50.00
60.00
70.00
80.0090.00
100.00
SELF (100) PHY (58) OPHTH (92)
NDR BDR PDR/VH
s
CHI-SQURE : 57.26132 DF : 4 SIGNIFICANCE : .00000
REVIEW OF 250 DIABETIC PATIENTS
05/13/10 6Eye Hospital & Retinal Laser Centre, Baroda
56.8
43.2
34.5
65.5 63.1
36.9
0.00
10.0020.00
30.0040.00
50.0060.00
70.0080.00
90.00100.00
TOTAL IDDM NIDDM
NDR DR
05/13/10 7Eye Hospital & Retinal Laser Centre, Baroda
56.8
12.4
30.834.5
16.4
49.1
63.1
11.3
25.6
0.0010.00
20.0030.00
40.0050.00
60.0070.0080.00
90.00100.00
TOTAL IDDM NIDDM
NDR BDR PDR/VH
05/13/10 8Eye Hospital & Retinal Laser Centre, Baroda
54.5
9.1
36.431.6
26.3
42.1
28.0
12.0
60.0
79.4
7.4
13.2
58.0
13.6
28.4
47.8
13.0
39.1
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
I (<5 YR) I (5-10YR) I (>10YR) N (<5 YR) N (5-10YR) N (>10YR)
NDR BDR PDR/VH
(11) (19) (25) (68) (81) (46)
05/13/10 9Eye Hospital & Retinal Laser Centre, Baroda
RETINOPATHY (Theoretical) RETINOPATHY (Theoretical) CLASSIFICATION:CLASSIFICATION:
BDR : Mild, Mod., BDR : Mild, Mod., Sev.Sev.
PPDR (Florid)PPDR (Florid) PDRPDR GLIOSIS AND TRDGLIOSIS AND TRD END STAGE : NVI, END STAGE : NVI,
NVGNVG
Clinically significant Macular oedema can exist at any stage
05/13/10 10Eye Hospital & Retinal Laser Centre, Baroda
BDR : MILDBDR : MILD
MICROANEURYSMSMICROANEURYSMS DOT HAEMORRHAGESDOT HAEMORRHAGES HARD EXUDATESHARD EXUDATES SOFT EXUDATESSOFT EXUDATES
OCCASIONAL
05/13/10 11Eye Hospital & Retinal Laser Centre, Baroda
MICROANEURYSMSMICROANEURYSMS
05/13/10 12Eye Hospital & Retinal Laser Centre, Baroda
BDR : MODERATEBDR : MODERATE
HARD EXUDATESSOFT EXUDATESRETINAL THICKENING
05/13/10 13Eye Hospital & Retinal Laser Centre, Baroda
SEVERE BDR & PPDR: SEVERE BDR & PPDR: Blot Haem Blot Haem 44 Quadr. Quadr. Venous Beading Venous Beading 22 Quadrants, Quadrants, IRMA IRMA 11 quadrant. quadrant.
( 45% go to PDR in one yr.)( 45% go to PDR in one yr.)
05/13/10 14Eye Hospital & Retinal Laser Centre, Baroda
PDR PDR VENOUS DILATATIONS AND VENOUS DILATATIONS AND BEADING, LARGE AREAS OF IRMA, BEADING, LARGE AREAS OF IRMA,
NON-PERFUSION, NVENON-PERFUSION, NVE
05/13/10 15Eye Hospital & Retinal Laser Centre, Baroda
PDR PDR VENOUS DILATATIONS AND VENOUS DILATATIONS AND BEADING, LARGE AREAS OF IRMA, BEADING, LARGE AREAS OF IRMA,
NON-PERFUSION, NVENON-PERFUSION, NVE
05/13/10 16Eye Hospital & Retinal Laser Centre, Baroda
PDR : NVDPDR : NVDSUBHYALOID AND VITREOUS SUBHYALOID AND VITREOUS
HEMORRHAGESHEMORRHAGES
High Risk : NVD > 2/3 rd, NVE 2 places, V.H
05/13/10 17Eye Hospital & Retinal Laser Centre, Baroda
STAGE OF FIBROUS STAGE OF FIBROUS PROLIFERATIONPROLIFERATION
GLIOSISGLIOSIS TRDTRD
05/13/10 18Eye Hospital & Retinal Laser Centre, Baroda
STAGE OF RUBIOSIS IRIDISSTAGE OF RUBIOSIS IRIDIS
NVINVI NVGNVG
05/13/10 19Eye Hospital & Retinal Laser Centre, Baroda
TREATMENT ORIENTED TREATMENT ORIENTED OUTLOOKOUTLOOK
WHEN & HOW SHOULD WE TREAT ?WHEN & HOW SHOULD WE TREAT ? IDENTIFY :IDENTIFY :
1 CSME & differentiate from1 CSME & differentiate from
MACULAR ISCHEMIA AND MACULAR ISCHEMIA AND
HAEMORRHAGE HAEMORRHAGE
2 PRE-PROLIFERATIVE STAGE2 PRE-PROLIFERATIVE STAGE
HIGHRISK FACTORSHIGHRISK FACTORS
05/13/10 20Eye Hospital & Retinal Laser Centre, Baroda
CSME
05/13/10 21Eye Hospital & Retinal Laser Centre, Baroda
International Clinical Classification of Diabetic Retinopathy, Severity of Diabetic Macular Edema,
Detailed Table
Mild Diabetic Macular Edema : Some retinal thickening or hard exudates in posterior pole but distant from the macula Moderate Diabetic Macular Edema : Retinal thickening or
hard exudates approaching the center of the macula but not
involving the centerSevere Diabetic Macular Edema : Retinal thickening or
hard exudates involving the center o the macula
05/13/10 22Eye Hospital & Retinal Laser Centre, Baroda
CSME : FOCAL CSME : FOCAL
05/13/10 23Eye Hospital & Retinal Laser Centre, Baroda
CSMECSME DIFFUSE DIFFUSE
05/13/10 24Eye Hospital & Retinal Laser Centre, Baroda
Differenciate from :Differenciate from :MACULAR ISCHEMIA, MACULAR ISCHEMIA,
05/13/10 25Eye Hospital & Retinal Laser Centre, Baroda
Differenciate from : Differenciate from : MACULAR HEMORRHAGEMACULAR HEMORRHAGE
05/13/10 26Eye Hospital & Retinal Laser Centre, Baroda
CLASSSIFY ACCORDING TO CLASSSIFY ACCORDING TO TREATMENT PROTOCOLS : TREATMENT PROTOCOLS :
BDR + CSME BDR + CSME ( Focal laser )( Focal laser ) PDR + CSME PDR + CSME ( FOCAL + PRP)( FOCAL + PRP) PDR+V.H. NONABSORBINGPDR+V.H. NONABSORBING
( PPVIT)( PPVIT) PDR+MACULAR TRACTION PDR+MACULAR TRACTION
( PPVIT)( PPVIT) TRD TRD ( PPVIT + ENDOLASER)( PPVIT + ENDOLASER)
05/13/10 27Eye Hospital & Retinal Laser Centre, Baroda
FACTORS MODIFYING FACTORS MODIFYING CLINICAL PRESENTATIONCLINICAL PRESENTATION
RVORVO CAROTID ARTERY CAROTID ARTERY
DISEASEDISEASE HYPERTENSIONHYPERTENSION
05/13/10 28Eye Hospital & Retinal Laser Centre, Baroda
54.5
9.1
36.431.6
26.3
42.1
28.0
12.0
60.0
79.4
7.4
13.2
58.0
13.6
28.4
47.8
13.0
39.1
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
80.00
90.00
100.00
I (<5 YR) I (5-10YR) I (>10YR) N (<5 YR) N (5-10YR) N (>10YR)
NDR BDR PDR/VH
CHI-SQURE :32.97361 DF : 10 SIGNIFICANCE : .00028
(11) (19) (25) (68) (81) (46)
COMPARISION OF 250 WITH I & N DIABETIC PATIENTS
05/13/10 29Eye Hospital & Retinal Laser Centre, Baroda
Today’s SituationToday’s Situation
Summary of the current situationSummary of the current situation Use brief bullets, discuss details verballyUse brief bullets, discuss details verbally Original assumptions that are no longer validOriginal assumptions that are no longer valid
05/13/10 30Eye Hospital & Retinal Laser Centre, Baroda
Available OptionsAvailable Options
State the alternative strategiesState the alternative strategies List advantages & disadvantages of eachList advantages & disadvantages of each State cost of each optionState cost of each option
05/13/10 31Eye Hospital & Retinal Laser Centre, Baroda
RecommendationRecommendation
Recommend one or more of the strategiesRecommend one or more of the strategies Summarize the results if things go as proposedSummarize the results if things go as proposed What to do nextWhat to do next Identify action itemsIdentify action items